Quest Diagnostics (DGX) PT Raised to $190 at Barclays
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $241.19 -0.65%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
Barclays analyst Stephanie Davis raised the price target on Quest Diagnostics (NYSE: DGX) to $190.00 (from $185.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Coinbase (COIN) PT Raised to $212 at Cantor Fitzgerald
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
- AutoZone (AZO) PT Lowered to $3,500; TD Cowen: 'Strong Execution But Not Immune To Industry DIY Headwinds'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
